Status:
UNKNOWN
Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study.
Lead Sponsor:
Narayana Medical College & Hospital
Conditions:
Severe Plaque Type Psoriasis
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Methotrexate (MTX) is considered the 'gold-standard' drug for the treatment of severe psoriasis. Health-related quality of life (HRQOL) is impaired in patients with psoriasis, more so if disease is se...
Eligibility Criteria
Inclusion
- Age range 18 to 65 years Both sexes Severe plaque-type psoriasis (BSA \>10% or PASI \>12) -
Exclusion
- Pregnancy Lactation Malignancy or immunosuppression including HIV Liver disease Renal disease Non compliant Psychiatric illness Hypersensitivity to methotrexate in the past
- \-
Key Trial Info
Start Date :
November 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02248792
Start Date
November 1 2013
Last Update
September 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Narayana Med College and Hospital
Nellore, Andhra Pradesh, India, 524003